PolyPeptide Group AG
SIX:PPGN

Watchlist Manager
PolyPeptide Group AG Logo
PolyPeptide Group AG
SIX:PPGN
Watchlist
Price: 28.85 CHF -3.67%
Market Cap: 955.8m CHF

Net Margin
PolyPeptide Group AG

-9.4%
Current
-5%
Average
1.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-9.4%
=
Net Income
-34.7m
/
Revenue
370.5m

Net Margin Across Competitors

No Stocks Found

PolyPeptide Group AG
Glance View

PolyPeptide Group AG is a contract development and manufacturing organization for clinical and approved commercial-stage peptide drug substances used in peptide-based therapeutics. The company is headquartered in Zug, Zug and currently employs 1,041 full-time employees. The company went IPO on 2021-04-29.

PPGN Intrinsic Value
HIDDEN
Show
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-9.4%
=
Net Income
-34.7m
/
Revenue
370.5m
What is the Net Margin of PolyPeptide Group AG?

Based on PolyPeptide Group AG's most recent financial statements, the company has Net Margin of -9.4%.

Back to Top